oxytetracycline

oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oxytetracycline?

oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oxytetracycline

MeSH term MeSH ID Detail
Jejunal Diseases D007579 3 associated lipids
Tracheal Diseases D014133 3 associated lipids
Esophagitis D004941 4 associated lipids
Babesiosis D001404 4 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Pemphigoid, Benign Mucous Membrane D010390 4 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Respiratory Tract Diseases D012140 4 associated lipids
Lymphogranuloma Venereum D008219 4 associated lipids
Balanitis D001446 4 associated lipids
Per page 10 20 50 100 | Total 137

PubChem Associated disorders and diseases

What pathways are associated with oxytetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oxytetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oxytetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oxytetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with oxytetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oxytetracycline?

Disease model

Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with oxytetracycline

Download all related citations
Per page 10 20 50 100 | Total 5138
Authors Title Published Journal PubMed Link
Brodie TA et al. Role of enzootic abortion and toxoplasmosis in an outbreak of abortion in a Scottish sheep flock. 1983 Vet. Rec. pmid:6649377
Strobel H et al. Targeted antibiotic treatment of lame sheep with footrot using either oxytetracycline or gamithromycin. 2014 Vet. Rec. pmid:24362004
Senturk S and Temizel M Clinical efficacy of rifamycin SV combined with oxytetracycline in the treatment of caseous lymphadenitis in sheep. 2006 Vet. Rec. pmid:16905739
Berri M et al. Spread of Coxiella burnetii infection in a flock of sheep after an episode of Q fever. 2005 Vet. Rec. pmid:16326967
Lo DY et al. Antimicrobial susceptibility and genetic characterisation of oxytetracycline-resistant Edwardsiella tarda isolated from diseased eels. 2014 Vet. Rec. pmid:24958553
Cook B Successful treatment of an outbreak of Salmonella dublin infection in calves using spectinomycin. 1973 Vet. Rec. pmid:4270651
Ferguson EG Changes in withdrawal periods. 2007 Vet. Rec. pmid:17617549
Brentnall C et al. Pharmacodynamics of oxytetracycline administered alone and in combination with carprofen in calves. 2012 Vet. Rec. pmid:22843613
Bousquet E et al. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens. 1997 Vet. Rec. pmid:9253829
Stevenson M Treatment for Haemobartonella felis in cats. 1997 Vet. Rec. pmid:9172302
Winter A Virulent foot rot in sheep. 1997 Vet. Rec. pmid:9248024
Walton JR Aerosols containing antibiotics and infectious drug resistance. 1971 Vet. Rec. pmid:4931992
Escudero E et al. Pharmacokinetics of oxytetracycline in goats: modifications induced by a long-acting formulation. 1994 Vet. Rec. pmid:7886888
Kumar R and Malik JK Effects of experimentally induced Theileria annulata infection on the pharmacokinetics of oxytetracycline in cross-bred calves. 1999 Jan-Feb Vet. Res. pmid:10081114
Archimbault P et al. Plasma bioavailability of 2 long-acting oxytetracycline formulations in the pig. 1994 Vet. Res. pmid:8087147
Kumar R and Malik JK Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves. 1998 Vet. Res. Commun. pmid:10066127
Ozdemir N and Yildirim M Bioequivalence study of two long-acting oxytetracycline formulations in sheep. 2006 Vet. Res. Commun. pmid:17139544
Kikuvi GM et al. The pharmacokinetics of a long-acting oxytetracycline formulation in healthy dogs and in dogs infected with Ehrlichia canis. 2001 Vet. Res. Commun. pmid:11469510
Kumi-Diaka J et al. Effect of chemotherapy on semen characteristics of Balami rams infected with Anaplasma ovis. 1988 Vet. Res. Commun. pmid:3188380
Errecalde JO et al. The effects of the method of calculation on the evaluation of the pharmacokinetic parameters of oxytetracycline after intravenous administration to calves. 1997 Vet. Res. Commun. pmid:9151411